Latest Pharmacology Stories
Above It All treatment centers are well known for their caring and effective drug rehabilitation programs, but they also have expert care for diabetics. Above it All Treatment Center now offers addiction treatment for diabetics type I and II. Lake Arrowhead, CA (PRWEB) May 17, 2013 Fighting addiction is hard enough for a person without extra health complications, but for diabetics, treatment is more difficult and complicated. Drug and alcohol rehab for diabetics involves additional...
Topricin Pain Relief and Healing Cream has been listed among nationally recommended over-the-counter (OTC) health products 2012 – 2013 in an initiative conducted by "U.S. News" in collaboration with the trade journal "Pharmacy Times." The product--which is not in mass market distribution yet--has earned the “No. 1 Pharmacists Recommended designation” in the “Topical Analgesics” category, and is the only homeopathic product on the recommendation list....
MJ Freeway is pleased to announce that Congressman Jared Polis will discuss the status of his H.R. 499 legislation in a very special Educational Series Webinar sponsored by the NCIA on May 22 Denver, CO (PRWEB) May 17, 2013 MJ Freeway is pleased to announce the next in its Educational Series Webinars with very special guest speaker Congressman Jared Polis (D-CO). This educational Webinar is sponsored by the National Cannabis Industry Association. In February, 2013 Congressman Polis...
- IIMD China 2013 Hot Topics Preview SHANGHAI, May 17, 2013 /PRNewswire/ -- Medical devices are any medical items that are neither a drug nor a biological product. In light of their different mechanisms, actions and regulatory requirements, medical device (MD) trail evaluations are much more complicated than drug trails due to their unique clinical practices. Currently, the EMEA only evaluates MD safety instead of evaluating both safety and efficacy (which is left to the...
WASHINGTON, May 17, 2013 /PRNewswire-USNewswire/ -- Personalized medicine and targeted therapies hold great potential to improve patient care and health care efficiency. At the Ninth Annual State of Personalized Medicine Luncheon hosted by the Personalized Medicine Coalition (PC), Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research at the Food and Drug Administration (FDA), will discuss how the FDA is dealing with the expanding field of personalized medicine,...
PHILADELPHIA, May 17, 2013 /PRNewswire/ -- Research explores data on treatments for psychiatric disorders; health economics and outcomes research also to be presented Shire plc (LSE: SHP, NASDAQ: SHPG), the global specialty biopharmaceutical company, announces that it will present scientific data in 7 poster presentations at the American Psychiatric Association (APA) 166th Annual Meeting in San Francisco, May 18-22. The data being presented...
Committee to Review Respiratory Safety Data Comparing MOXDUO with Components SYDNEY and BEDMINSTER, N.J., May 17, 2013 /PRNewswire/ -- QRxPharma Limited (ASX: QRX and OTCQX: QRXPY) announced today the US Food and Drug Administration (FDA) has set 17 July 2013 as the date of the Advisory Committee meeting to consider the Company's resubmitted MOXDUO( )New Drug Application (NDA). "The timing is within the expected date range of late June to late July," said Dr. John Holaday,...
FARMINGTON, Conn., May 17, 2013 /PRNewswire-iReach/ -- The escalation of new biological drugs, including antibodies and recombinant proteins, is placing renewed emphasis on alternate delivery technologies. Alternate delivery technologies are on the rise as a number of factors are converging to create both risk and opportunity for pharmaceutical makers and their delivery device partners. These include new classes of drugs for previously refractory conditions, the growing trend toward...
Combivent® Respimat® (ipratropium bromide and albuterol) Inhalation Spray will become the only available short-acting bronchodilator offering two different medicines in a single inhaler RIDGEFIELD, Conn., May 17, 2013 /PRNewswire/ -- As part of the company's commitment to chronic obstructive pulmonary disease (COPD) patients, Boehringer Ingelheim Pharmaceuticals, Inc., a leader in respiratory health, is updating healthcare professionals (HCPs) and patients that the transition to...
CANTON, Mass., May 17, 2013 /PRNewswire/ -- Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, today announced that the Company's President and CEO, Michael Heffernan, will present the Company's corporate overview on Monday, May 20, 2013 at 1:30pm EDT at the UBS Global Health Care Conference. The conference will be held at the Sheraton New York Hotel in New York City. The Company's lead development program is Oxycodone DETERx(®), an abuse-deterrent,...
Latest Pharmacology Reference Libraries
The European Journal of Medical Chemistry is a peer-reviewed scientific journal for medical chemistry. It is published by Elsevier. It was established in 1966 under the title Chimica Therapeutica. That name was maintained until 1973. Even after changing to its current name in 1974, the journal was still subtitled Chimica Therapeutica until 1981; from 1982 to 1986 it was subtitled Chimie Therapeutique, indicating its French origin. The Journal publishes studies on all aspects of medicinal...
Bursera graveolens or Palo Santo is a tree indigenous to South America in Argetina, Paraguay, Boliva and coastal areas of Ecuador. Palo Santo means "holy wood" in English and belongs in the same family as frankincense and myrrh. Although it has been used in homeopathic medicine for years, most recently it is the extraction of essential oils that has put this plant in the spotlight. Limonene, a-Terpineol, Menthofuran and Carvone are a few of the oils derived from this plant. Native...
Datura wrightii (a poisonous weed) is sometimes used as a hallucinogen. It is commonly called Sacred Datura. Datura wrightii is classified as a deliriant, or an anticholinergic. In the US it is, however, called Western Jimson Weed.
